Fresenius Medical Care AG & Co. KGaA (ETR: FME – Get a rating) received a target price of €48.70 ($52.37) from stock analysts at JPMorgan Chase & Co. in a note issued Wednesday to investors, Borsen Zeitung reports. JPMorgan Chase & Co.The stock’s target price suggests a potential decline of 18.40% from the stock’s previous close.
FME has been the subject of several other research reports. Stifel Nicolaus set a price target of €60.00 ($64.52) on shares of Fresenius Medical Care AG & Co. KGaA in a Friday, February 4 research report. Kepler Capital Markets set a target price of €59.00 ($63.44) on shares of Fresenius Medical Care AG & Co. KGaA in a Monday, January 10 report. UBS Group set a target price of €75.00 ($80.65) on shares of Fresenius Medical Care AG & Co. KGaA in a report released Tuesday. Credit Suisse Group set a target price of €61.00 ($65.59) on shares of Fresenius Medical Care AG & Co. KGaA in a Monday, February 28 report. Finally, Jefferies Financial Group set a target price of €53.00 ($56.99) on shares of Fresenius Medical Care AG & Co. KGaA in a Tuesday, February 22 report. One financial analyst gave the stock a sell rating, four gave the company a hold rating and five gave the company a buy rating. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of €65.47 ($70.40).
ETR FME opened at €59.68 ($64.17) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 52-week minimum of €50.98 ($54.82) and a 52-week maximum of €71.14 ($76.49). The company has a market capitalization of $17.49 billion and a P/E ratio of 18.04. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt ratio of 95.29. The company has a 50-day moving average price of €59.65 and a 200-day moving average price of €58.61.
Fresenius Medical Care AG & Co. KGaA Company Profile (Get a rating)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.
Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .